Keystone Symposium: Multispecific Immune Cell Engagers for Cancer Immunotherapy

Raffi Tonikian, Director, Translational Biomarkers, will be presenting "Streamlining T-cell engager development with a diverse panel of fully human CD3-binding antibodies, bispecific engineering technology, and an integrated discovery engine" at the Keystone Symposia on Multispecific Immune Cell Engagers for Cancer Immunotherapy.